ID

32557

Descrizione

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Keywords

versioni (2)
  1. 06/11/18 06/11/18 -
  2. 06/12/18 06/12/18 -
Titolare del copyright

GSK group of companies

Caricato su

6 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Inglese

Study conclusion

1 moduli  
  1. StudyEvent: ODM
    1. Study conclusion
Study conclusion details
Descrizione

Study conclusion details

Date of subject completion or withdrawal
Descrizione

Date of subject completion or withdrawal

Tipo di dati

date

Was the subject withdrawn from the study?
Descrizione

Was the subject withdrawn from the study?

Tipo di dati

boolean

If YES, complete primary reason for withdrawal
Descrizione

If YES, complete primary reason for withdrawal

1. Adverse event
Descrizione

record details on AE or SAE forms as appropriate)

Tipo di dati

boolean

2. Lack of efficacy
Descrizione

Check all that apply. If none, select "No Subreasons"

Tipo di dati

text

3. Protocol Deviation
Descrizione

Check all that apply. If none, select "No Subreasons"

Tipo di dati

text

4. Subject reached protocol defined stopping criteria
Descrizione

4. Subject reached protocol defined stopping criteria

Tipo di dati

text

5. Study closed/terminated
Descrizione

5. Study closed/terminated

Tipo di dati

boolean

6. Lost to Follow-Up
Descrizione

6. Lost to Follow-Up

Tipo di dati

boolean

7. Investigator discretion, specify
Descrizione

Select this reason if none of the other primary reasons are appropriate

Tipo di dati

text

8. Withdrew consent, specify
Descrizione

Select this reason if none of the other primary reasons are appropriate

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

Study conclusion

1 moduli
  1. StudyEvent: ODM
    1. Study conclusion
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study conclusion details
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
Item Group
If YES, complete primary reason for withdrawal
1. Adverse event
Item
1. Adverse event
boolean
Item
2. Lack of efficacy
text
2. Lack of efficacy
Code List
2. Lack of efficacy
CL Item
No subreasons (1)
CL Item
Exacerbation (2)
Item
3. Protocol Deviation
text
3. Protocol Deviation
Code List
3. Protocol Deviation
CL Item
No subreasons (1)
CL Item
Pregnancy (2)
CL Item
Lack of adherence (3)
CL Item
Prohibited medication use (4)
Item
4. Subject reached protocol defined stopping criteria
text
Subject reached protocol defined stopping criteria
Code List
4. Subject reached protocol defined stopping criteria
CL Item
Yes (1)
CL Item
No (2)
CL Item
Liver function test abnormality (3)
5. Study closed/terminated
Item
5. Study closed/terminated
boolean
6. Lost to Follow-Up
Item
6. Lost to Follow-Up
boolean
7. Investigator discretion, specify
Item
7. Investigator discretion, specify
text
8. Withdrew consent, specify
Item
8. Withdrew consent, specify
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial